OLEVRA Welcomes You

Biological cancer therapy with endogenous dendritic cells

The dream of fighting cancer with the own immune system is possible by cultivating the own (autologous) dendritic cells. In dendritic cell therapy, unlike traditional anticancer treatments, the body’s immune system is “trained” to fight cancer. This procedure is very gentle and practically has no side effects. Therefore, no hospital stay is required, and the therapy can be performed on an outpatient basis. Depending on the size, it is necessary to preliminary remove the tumor by surgery. Dendritic cell therapies have also been successfully conducted in patients who have undergone multiple chemotherapy regimens and have no significant healing. The treatment is supplemented with biological products such as Resveratrol and Curcumin, as well as with minerals and vitamins to provide optimal state of the immune system.

The diet plays a very important role. Some foods and luxury foods should not be consumed. In general, the level of carbohydrates should be low, but the proportion of proteins and fats should be higher. Approximately 100 years ago, the incidence of cancer was 1 in 500, so one in 500 people suffered from cancer, and today the ratio is from 1 to 3. So it makes sense to look at how people ate 100 years ago and how does it happen today? Of course, environmental pressure and influences play a big role and everyone should consider how to improve their personal health situation. Although the treatment of cancer with dendritic cell has been very successful for more than 10 years, only 8% of all physicians know this method of treatment. This is an inherent blood treatment from which the pharmaceutical industry does not gain.



Early detection saves lives

For over 20 years there has been a recognized test that determines with 95% accuracy whether the disease is cancerous or not.  It is more effective and less risky than any other test method and costs about 200 euro. This is the AMAS (anti-malignant antibody in serum) test. The AMAS test only responds to malignant tumors. Using this blood test, it is possible to diagnose cancer by up to 19 months earlier than any other method. This advantage and the safety of the result help the patient to take unnecessary fears and enable him/her to respond in a timely manner.